Dean Schorno

EVP & CFO at Rigel Pharmaceuticals

Dean Schorno has a vast experience in the financial sector, holding various CFO and executive positions at companies such as Rigel Pharmaceuticals Inc., 23andMe, and Adaptive Biotechnologies Corp. Prior to that, Dean founded their own financial and operations advisory services firm. With a BS in Finance & Accounting from the University of California, Berkeley, Haas School of Business, Dean Schorno has a strong educational background to support their extensive professional experience.


Previous companies

23andMe logo


  • EVP & CFO

    Current role

View in org chart